AI MARKET SCANNING

$MBX

MBX Biosciences Inc

United StatesUNITED STATES
FREE PREVIEW
🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP0.36%
MAX GAP RECORD5.75%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $MBX

EXECUTIONS0
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
RADAR SCANNING: WAITING FOR NEXT CATALYST
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY1.7%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL